HETEROLOGOUS EXPRESSION OF RECOMBINANT SCYGONADIN ANTIMICROBIAL PEPTIDE FROM MUD CRAB Scylla serrata

Authors

  • NURFARHANA ROSLI School of Fundamental Science, Universiti Malaysia Terengganu, Terengganu
  • FARAH AYUNIE MOHD ZAIN School of Fundamental Science, Universiti Malaysia Terengganu, Terengganu
  • SANDRA CATHERINE ZAINATHAN School of Fisheries and Aquaculture Science, Universiti Malaysia Terengganu, Terengganu
  • SITI NOR KHADIJAH ADDIS School of Fundamental Science, Universiti Malaysia Terengganu, Terengganu

Keywords:

Antimicrobial peptide, scygonadin, Scylla serrata, recombinant protein, IMAC purification

Abstract

Antimicrobial peptides (AMPs) are the most common immune effectors in invertebrates that functions as the first line of defence against microbial infection. Scygonadin is an AMP which can be found in the seminal plasma of Scylla serrata. Preceding studies had shown that scygonadin have the ability to exhibit wide antimicrobial activities. Nonetheless, analysis of the antimicrobial properties of scygonadin is significantly dependent on acquiring sufficient amounts of the protein from mud crab, and this was proven difficult. Further functional studies of scygonadin and its commercial applications require a development of efficient, sustainable and cost-effective heterologous protein production. To address this issue, an expression plasmid containing 387 bp of scygonadin gene of Scylla serrata was cloned into pBAD/Myc-His A, expressed in TOP10 cells with L-arabinose as expression inducer, followed by protein purification by using immobilized metal affinity chromatography (IMAC). The optimal expression condition was determined by incubation with 0.02% of L-arabinose for 4 hours at 37°C. A total of 2 mg/ml of purified scygonadin with the molecular weight of ~17kDa was succesfully obtained. The results demonstrated that the recombinant scygonadin was successfully produced in heterologous expression system which may allow production of scygonadin in large quantities for further research and commercial application.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Aoki, W. & Ueda, M. 2013. Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics. Pharmaceuticals, 6: 1055- 1081.

Bahar, A.A. & Ren, D. 2013. Antimicrobial Peptides. Pharmaceuticals, 6(12): 1543-1575.

Bentley, W.E., Mirjalili, N., Andersen, D.C., Davis, R.H. & Kompala, D.S. 1990. Plasmid-encoded protein: the principal factor in the “metabolic burden” associated with recombinant bacteria. Biotechnology. Bioengineering, 35: 668-681.

Berg, J.M., Tymoczko, J.L. & Stryer, L. 2002. Biochemistry. 5th edition. New York: W H Freeman. Section 4.1, The Purification of Proteins Is an Essential First Step in Understanding Their Function. Available from: h t t p s : / / w w w . n c b i . n l m . n i h . g o v / b o o k s /NBK22410/

Bornhorst, J.A. & Falke, J.J. 2000. Purification of proteins using polyhistidine affinity tags. Methods in Enzymology, 326: 245-254.

Chen, L., Gao, L., Fang, W. & Golubovic, L. 2012. How the antimicrobial peptides kill bacteria: computational physics insights. Communications in Computational Physics, 11(3): 709-725.

Guzman, L.M., Belin, D., Carson, M.J. & Beckwith, J.O.N. 1995. Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. Journal of Bacteriology, 177(14): 4121-4130.

Hancock, R.E.W. & Patrzykat, A. 2002. Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Current Drug Targets, 2(1): 79-83.

Hoebe, K., Jansen, E. & Beutler, B. 2004. The interface between innate and adaptive immunity. Natural Immunology, 5: 971-974.

Huang, W.S., Wang, K.J., Yang, M., Cai, J.J., Li, S.J. & Wang, G.Z. 2006. Purication and part characterization of a novel antibacterial protein Scygonadin, isolated from the seminal plasma of mud crab Scylla serrata (Forskål, 1775), Journal of Experimental Marine Biology and Ecology, 339: 37-42.

Iwanaga, S. & Lee, B.L. 2005. Recent advances in the innate immunity of invertebrate animals. Journal of Biochemistry and Molecular Biology, 38(2): 128-150.

Malanovic, N. & Lohner, K. 2016. Antimicrobial peptides targeting Gram-positive bacteria. Pharmaceuticals, 9(3): 59.

Peng, H., Yang, M., Huang, W.S., Ding, J., Qu, H.D., Cai, J.J., Zhang, N. & Wang, K.J. 2010. Soluble expression and purication of a crab antimicrobial peptide scygonadin in different expression plasmids and analysis of its antimicrobial activity. Protein Expression and Purification Elseveir, 70: 109-115.

Peng, H., Liu, H.P., Chen, B., Hao, H. & Wang, K.J. 2012. Optimized production of scygonadin in Pichia pastoris and analysis of its antimicrobial and antiviral activities. Protein Expression and Purification Elsevier, 82: 37-44.

Pushpanathan, M., Gunasekaran, P. & Rajendhran, J. 2013. Antimicrobial peptides: versatile biological properties. International Journal of Peptides, 15.

Rosano, G.L. & Ceccarelli, E.A. 2014. Recombinant protein expression in Escherichia coli: advances and challenges. Frontiers in Microbiology, 5: 172.

Zhang, Y., Shang, X., Lai, S., Zhang, G., Liang, Y. & Wen, T. 2012. Development and Application of an Arabinose-Inducible Expression System by Facilitating Inducer Uptake in Corynebacterium glutamicum. Applied and Environmental Microbiology, 78(16): 5831-5838.

Published

20-03-2019

How to Cite

ROSLI, N., MOHD ZAIN, F. A. ., ZAINATHAN, S. C., & ADDIS, S. N. K. . (2019). HETEROLOGOUS EXPRESSION OF RECOMBINANT SCYGONADIN ANTIMICROBIAL PEPTIDE FROM MUD CRAB Scylla serrata. Malaysian Applied Biology, 48(1), 95–100. Retrieved from https://jms.mabjournal.com/index.php/mab/article/view/2297